NewAmsterdam Pharma (NAMS) EBT (2023 - 2026)
NewAmsterdam Pharma (NAMS) reported EBT of -$48.4 million for Q1 2026, down 22.55% on a YoY basis from -$62.5 million in Q1 2025, and up 35.35% sequentially from -$74.9 million in Q4 2025.
NewAmsterdam Pharma (NAMS) EBT (2023 - 2026) Analysis & Trends
NewAmsterdam Pharma (NAMS) has 4 years of EBT data on file, last reported at -$48.4 million in Q1 2026.
- For the quarter ending Q1 2026, EBT fell 22.55% year-over-year to -$48.4 million; the trailing twelve-month figure through Mar 2026 stood at -$212.7 million (down 13.54% YoY), and the FY2025 full-year result was -$203.8 million, up 15.64% from the prior year.
- EBT grew to -$48.4 million in Q1 2026, from -$74.9 million in the prior quarter.
- In the past five years, EBT ranged from a high of $58.1 million in Q4 2023 to a low of -$93.8 million in Q1 2024.
- A 4-year average of -$43.3 million and a median of -$42.0 million in 2023 frame the typical range for EBT.
- Across the five-year window, EBT jumped 64.68% in 2024 and tumbled 332.51% in 2025, its largest moves.
- Tracing NAMS's EBT over 4 years: stood at $58.1 million in 2023, then slumped by 258.69% to -$92.2 million in 2024, then climbed by 18.72% to -$74.9 million in 2025, then surged by 35.35% to -$48.4 million in 2026.
- Business Quant data shows NAMS's EBT at -$48.4 million in Q1 2026, -$74.9 million in Q4 2025, and -$72.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | NewAmsterdam Pharma | 3.72 Bn | 3.72 Bn | - | -48.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48.44 Mn |
| Dec 31, 2025 | -74.92 Mn |
| Sep 30, 2025 | -72.01 Mn |
| Jun 30, 2025 | -17.36 Mn |
| Mar 31, 2025 | -39.53 Mn |
| Dec 31, 2024 | -92.18 Mn |
| Sep 30, 2024 | -16.65 Mn |
| Jun 30, 2024 | -39.01 Mn |
| Mar 31, 2024 | -93.77 Mn |
| Dec 31, 2023 | 58.09 Mn |
| Sep 30, 2023 | -47.13 Mn |
| Jun 30, 2023 | -38.29 Mn |
| Mar 31, 2023 | -42.02 Mn |